Marketgenius
Marketgenius

Ultragenyx Pharmaceutical Inc.

NASDAQ-GS: RARE
Price: 21,91 USD
-1,40 (6,01%)↓ today
Price at Jun 5, 4:00:01 PM EDT • Market Closed
Loading...

Stock Details

Is it expensive?

Trailing P/E Ratio

Trailing P/E Ratio

Explainer
Trailing P/E shows what you are paying for each dollar of last year's earnings. It answers: "How expensive is this stock relative to its past year's profits?"
Related Articles

-3,76

Forward P/E Ratio

Forward P/E Ratio

Explainer
Forward P/E shows what you are paying for each dollar of next year's projected earnings. It answers: "How expensive is this stock relative to its expected future profits?"
Related Articles

24,10

PEG Ratio

PEG Ratio

Explainer
PEG Ratio measures if a stock is expensive relative to its growth rate. It answers: "Am I paying a fair price for growth?"
Related Articles

-0,22

Enterprise Value to EBITDA

-6,03

Price-to-Sales (TTM)

Price-to-Sales (TTM)

Explainer
Price-to-Sales (TTM) shows what you pay for each dollar of the company's revenue. It answers: "How expensive is this stock relative to sales?"
Related Articles

3,42

Price-to-Book (MRQ)

-9,63

Book Value per Share (MRQ)

-2,41

Market Cap

Market Cap

Explainer
Market Cap calculates a company's market value. It answers: "How big is this company and what size risk am I taking?"
Related Articles

2,16B

Enterprise Value

2,99B

Is it profitable?

Net Profit Margin (TTM)

Net Profit Margin (TTM)

Explainer
Net Profit Margin (TTM) shows what percentage of revenue remains after all costs. It answers: "How much does the company keep as a final profit?"

-90,90%

Gross Profit Margin

Gross Profit Margin

Explainer
Gross Profit Margin shows what percentage of revenue remains after direct costs. It answers: "How much does the company keep before operating costs?"

77,94%

Diluted EPS (TTM)

Diluted EPS (TTM)

Explainer
Diluted EPS (TTM) shows the profit per share over the last 12 months. It answers: "How profitable is each share I buy?"
Related Articles

-6,10

Return on Equity (TTM)

787,67%

Revenue (TTM)

670,00M

Is it growing?

Revenue Growth (MRQ)

-2,20%

Earnings Growth (YOY)

-2,36%

Is it risky?

Beta

0,39

Debt to Equity (MRQ)

-5,24

Current Ratio (MRQ)

2,02

Total Debt (MRQ)

1,20B

Who owns it?

Institutional Ownership

104,12%

Insider Ownership

3,46%

Short Interest

14,68%

Shares Outstanding

98,32M

Shares Float

94,50M

Does it pay?

Forward Dividend Yield

0,00%

Payout Ratio

0,00%

Ex. Dividend Date

--

Dividend Date

--

How much cash?

Total Cash (MRQ)

413,00M

Operating Cash Flow (TTM)

-497,00M

Levered Free Cash Flow (TTM)

-219,09M

Total Cash per Share (MRQ)

4,21

Indicators

Biotechnology

Operating Cash Flow

-497,00M

÷

Net Income

-609,00M

=

Backed by Cash

0.82

Earnings closely match operating cash flow. This is the healthy baseline: profits are genuine and not artificially inflated.

Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.

Loading...

Indicators

Biotechnology

Operating Cash Flow

-497,00M

÷

Net Income

-609,00M

=

Backed by Cash

0.82

Earnings closely match operating cash flow. This is the healthy baseline: profits are genuine and not artificially inflated.

Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.

Stock Details

Is it expensive?

Trailing P/E Ratio

Trailing P/E Ratio

Explainer
Trailing P/E shows what you are paying for each dollar of last year's earnings. It answers: "How expensive is this stock relative to its past year's profits?"
Related Articles

-3,76

Forward P/E Ratio

Forward P/E Ratio

Explainer
Forward P/E shows what you are paying for each dollar of next year's projected earnings. It answers: "How expensive is this stock relative to its expected future profits?"
Related Articles

24,10

PEG Ratio

PEG Ratio

Explainer
PEG Ratio measures if a stock is expensive relative to its growth rate. It answers: "Am I paying a fair price for growth?"
Related Articles

-0,22

Enterprise Value to EBITDA

-6,03

Price-to-Sales (TTM)

Price-to-Sales (TTM)

Explainer
Price-to-Sales (TTM) shows what you pay for each dollar of the company's revenue. It answers: "How expensive is this stock relative to sales?"
Related Articles

3,42

Price-to-Book (MRQ)

-9,63

Book Value per Share (MRQ)

-2,41

Market Cap

Market Cap

Explainer
Market Cap calculates a company's market value. It answers: "How big is this company and what size risk am I taking?"
Related Articles

2,16B

Enterprise Value

2,99B

Is it profitable?

Net Profit Margin (TTM)

Net Profit Margin (TTM)

Explainer
Net Profit Margin (TTM) shows what percentage of revenue remains after all costs. It answers: "How much does the company keep as a final profit?"

-90,90%

Gross Profit Margin

Gross Profit Margin

Explainer
Gross Profit Margin shows what percentage of revenue remains after direct costs. It answers: "How much does the company keep before operating costs?"

77,94%

Diluted EPS (TTM)

Diluted EPS (TTM)

Explainer
Diluted EPS (TTM) shows the profit per share over the last 12 months. It answers: "How profitable is each share I buy?"
Related Articles

-6,10

Return on Equity (TTM)

787,67%

Revenue (TTM)

670,00M

Is it growing?

Revenue Growth (MRQ)

-2,20%

Earnings Growth (YOY)

-2,36%

Is it risky?

Beta

0,39

Debt to Equity (MRQ)

-5,24

Current Ratio (MRQ)

2,02

Total Debt (MRQ)

1,20B

Who owns it?

Institutional Ownership

104,12%

Insider Ownership

3,46%

Short Interest

14,68%

Shares Outstanding

98,32M

Shares Float

94,50M

Does it pay?

Forward Dividend Yield

0,00%

Payout Ratio

0,00%

Ex. Dividend Date

--

Dividend Date

--

How much cash?

Total Cash (MRQ)

413,00M

Operating Cash Flow (TTM)

-497,00M

Levered Free Cash Flow (TTM)

-219,09M

Total Cash per Share (MRQ)

4,21